Study Stopped
The COVID-19 outbreak began, precluding further participant recruitment for this protocol, which could only be conducted in-person. A decision was made that ample data was available to end data collection earlier than anticipated.
Impulsivity and Alcohol Response
IDEA
Individual Differences in the Effects of Alcohol (IDEA) Study
3 other identifiers
interventional
24
1 country
1
Brief Summary
Impulsivity, a well-known risk factor predicting negative outcomes, refers broadly to a proclivity towards rapid action with a suboptimal regard for future consequences. Importantly, impulsivity is a multidimensional construct incorporating generalized and behavioral facets. However, underlying mechanisms linking facets of impulsivity to high-risk drinking remain uncertain. Such mechanisms, if uncovered, may be more appropriate intervention targets than impulsivity directly. Similar to impulsivity, subjective response to alcohol (SR), or individual differences in sensitivity to the pharmacologic effects of alcohol, is an established risk factor for alcohol use disorder. Specifically, experiencing heightened rewarding stimulation and dampened aversive sedation from alcohol are related to high-risk drinking. Theory and recent findings indicate SR and impulsivity may be related, suggesting SR may be a mechanism linking facets of impulsivity to high-risk drinking. However, findings linking impulsivity to SR were all from secondary data analyses and most studies reported on only a single measure of impulsivity. For these reasons, an original data collection using laboratory alcohol administration methods is needed to address which facets of impulsivity are related to SR among young adult drinkers and whether these effects manifest while blood alcohol concentrations are increasing or declining. This study will utilize a laboratory alcohol administration design to investigate whether distinct facets of impulsivity (i.e., generalized, choice, response) are related to subjective responses (i.e., stimulation and sedation) following alcohol administration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for early_phase_1
Started May 2019
Typical duration for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 6, 2018
CompletedFirst Posted
Study publicly available on registry
November 9, 2018
CompletedStudy Start
First participant enrolled
May 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 17, 2022
CompletedDecember 6, 2023
November 1, 2023
1.1 years
November 6, 2018
November 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Biphasic Alcohol Effects Scale
Biphasic Alcohol Effects Scale is a 14-item, 2-factor model including stimulant and sedative alcohol effects. The minimum value for each of the 2 factors is 0 and the maximum is 70. Higher scores indicate greater stimulation and sedation for each factor, respectively.
Up to 6 hours
Secondary Outcomes (2)
Subjective Effects of Alcohol Scale
Up to 6 hours
Alcohol Reward
Up to 6 hours
Study Arms (2)
Young Adult Heavy Drinkers Group 1
ACTIVE COMPARATORYoung adult heavy drinkers, aged 21-30, will be administered varying doses of oral alcohol.
Young Adult Heavy Drinkers Group 2
ACTIVE COMPARATORYoung adult heavy drinkers, aged 21-30, will be administered varying doses of oral alcohol.
Interventions
Participants will complete two drinking sessions.
Eligibility Criteria
You may qualify if:
- Be between the ages of 21-30
- Be able to read English and complete study evaluations
- Drink alcohol regularly
- Be willing to consume vodka-based alcoholic beverages
You may not qualify if:
- Have positive urine screen results at the in-person screening or on the day of an alcohol drinking session for illegal drugs
- A woman who is pregnant, nursing, or refuses to use a reliable method of birth control.
- A current undergraduate or graduate student at any level in one of the departments that make up the College of Health and Human Performance (HHP) at the University of Florida (UF), where Dr. Leeman's faculty appointment is.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
EDGE Lab
Gainesville, Florida, 32610, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yan Wang
University of Florida
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 6, 2018
First Posted
November 9, 2018
Study Start
May 1, 2019
Primary Completion
May 31, 2020
Study Completion
October 17, 2022
Last Updated
December 6, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share